Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 1
1987 2
1988 5
1989 2
1990 4
1991 4
1992 3
1993 3
1994 3
1995 5
1996 10
1997 10
1998 5
1999 10
2000 7
2001 9
2002 10
2003 13
2004 15
2005 13
2006 15
2007 9
2008 9
2009 19
2010 21
2011 22
2012 21
2013 15
2014 18
2015 25
2016 33
2017 47
2018 32
2019 40
2020 45
2021 46
2022 34
2023 44
2024 30

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

613 results

Results by year

Filters applied: . Clear all
Page 1
Goals of COPD treatment: Focus on symptoms and exacerbations.
Vogelmeier CF, Román-Rodríguez M, Singh D, Han MK, Rodríguez-Roisin R, Ferguson GT. Vogelmeier CF, et al. Respir Med. 2020 May;166:105938. doi: 10.1016/j.rmed.2020.105938. Epub 2020 Mar 21. Respir Med. 2020. PMID: 32250871 Free article. Review.
Global Initiative for Chronic Obstructive Lung Disease 2023 Report: GOLD Executive Summary.
Agustí A, Celli BR, Criner GJ, Halpin D, Anzueto A, Barnes P, Bourbeau J, Han MK, Martinez FJ, Montes de Oca M, Mortimer K, Papi A, Pavord I, Roche N, Salvi S, Sin DD, Singh D, Stockley R, López Varela MV, Wedzicha JA, Vogelmeier CF. Agustí A, et al. Among authors: vogelmeier cf. Eur Respir J. 2023 Apr 1;61(4):2300239. doi: 10.1183/13993003.00239-2023. Print 2023 Apr. Eur Respir J. 2023. PMID: 36858443 Free PMC article.
Dupilumab for COPD with Type 2 Inflammation Indicated by Eosinophil Counts.
Bhatt SP, Rabe KF, Hanania NA, Vogelmeier CF, Cole J, Bafadhel M, Christenson SA, Papi A, Singh D, Laws E, Mannent LP, Patel N, Staudinger HW, Yancopoulos GD, Mortensen ER, Akinlade B, Maloney J, Lu X, Bauer D, Bansal A, Robinson LB, Abdulai RM; BOREAS Investigators. Bhatt SP, et al. Among authors: vogelmeier cf. N Engl J Med. 2023 Jul 20;389(3):205-214. doi: 10.1056/NEJMoa2303951. Epub 2023 May 21. N Engl J Med. 2023. PMID: 37272521 Clinical Trial.
An Updated Definition and Severity Classification of Chronic Obstructive Pulmonary Disease Exacerbations: The Rome Proposal.
Celli BR, Fabbri LM, Aaron SD, Agusti A, Brook R, Criner GJ, Franssen FME, Humbert M, Hurst JR, O'Donnell D, Pantoni L, Papi A, Rodriguez-Roisin R, Sethi S, Torres A, Vogelmeier CF, Wedzicha JA. Celli BR, et al. Among authors: vogelmeier cf. Am J Respir Crit Care Med. 2021 Dec 1;204(11):1251-1258. doi: 10.1164/rccm.202108-1819PP. Am J Respir Crit Care Med. 2021. PMID: 34570991 Free article. No abstract available.
Dupilumab for COPD with Blood Eosinophil Evidence of Type 2 Inflammation.
Bhatt SP, Rabe KF, Hanania NA, Vogelmeier CF, Bafadhel M, Christenson SA, Papi A, Singh D, Laws E, Patel N, Yancopoulos GD, Akinlade B, Maloney J, Lu X, Bauer D, Bansal A, Abdulai RM, Robinson LB; NOTUS Study Investigators. Bhatt SP, et al. Among authors: vogelmeier cf. N Engl J Med. 2024 Jun 27;390(24):2274-2283. doi: 10.1056/NEJMoa2401304. Epub 2024 May 20. N Engl J Med. 2024. PMID: 38767614 Clinical Trial.
Exacerbations of COPD.
Viniol C, Vogelmeier CF. Viniol C, et al. Among authors: vogelmeier cf. Eur Respir Rev. 2018 Mar 14;27(147):170103. doi: 10.1183/16000617.0103-2017. Print 2018 Mar 31. Eur Respir Rev. 2018. PMID: 29540496 Free PMC article. Review.
COPD 2020: changes and challenges.
Agustí A, Vogelmeier C, Faner R. Agustí A, et al. Among authors: vogelmeier c. Am J Physiol Lung Cell Mol Physiol. 2020 Nov 1;319(5):L879-L883. doi: 10.1152/ajplung.00429.2020. Epub 2020 Sep 23. Am J Physiol Lung Cell Mol Physiol. 2020. PMID: 32964724 Free article. No abstract available.
COPD and multimorbidity: recognising and addressing a syndemic occurrence.
Fabbri LM, Celli BR, Agustí A, Criner GJ, Dransfield MT, Divo M, Krishnan JK, Lahousse L, Montes de Oca M, Salvi SS, Stolz D, Vanfleteren LEGW, Vogelmeier CF. Fabbri LM, et al. Among authors: vogelmeier cf. Lancet Respir Med. 2023 Nov;11(11):1020-1034. doi: 10.1016/S2213-2600(23)00261-8. Epub 2023 Sep 8. Lancet Respir Med. 2023. PMID: 37696283 Review.
From GOLD 0 to Pre-COPD.
Han MK, Agusti A, Celli BR, Criner GJ, Halpin DMG, Roche N, Papi A, Stockley RA, Wedzicha J, Vogelmeier CF. Han MK, et al. Among authors: vogelmeier cf. Am J Respir Crit Care Med. 2021 Feb 15;203(4):414-423. doi: 10.1164/rccm.202008-3328PP. Am J Respir Crit Care Med. 2021. PMID: 33211970 Free PMC article. No abstract available.
Definition and Nomenclature of Chronic Obstructive Pulmonary Disease: Time for Its Revision.
Celli B, Fabbri L, Criner G, Martinez FJ, Mannino D, Vogelmeier C, Montes de Oca M, Papi A, Sin DD, Han MK, Agusti A. Celli B, et al. Among authors: vogelmeier c. Am J Respir Crit Care Med. 2022 Dec 1;206(11):1317-1325. doi: 10.1164/rccm.202204-0671PP. Am J Respir Crit Care Med. 2022. PMID: 35914087 Free PMC article. No abstract available.
613 results